CD8+ T cells reactive to these neoantigens were enriched from these PBMCs and displayed potent and specific cytotoxicity against NSCLC cell lines bearing T790M mutation in an HLA-A*02:01-restricted manner [37]. This evidence concerns the gene HLA-A and non-small cell lung carcinoma.